{
  "company": {
    "name": "Junhemeng Biopharmaceutical",
    "website": "https://jhm-biopharma.com/",
    "record": "https://startuphistory.org/c/jhm-biopharma.com"
  },
  "status": null,
  "history_since": "2026-11-06T17:26:50.539Z",
  "baseline": {
    "snapshot_id": "37767e4385be58d4193b1bf76fa555afb0426becbcba13ef150ee11241a6e5f5",
    "observed_at": "2026-11-06T17:26:50.539Z",
    "headline": "君合盟生物制药（杭州）股份有限公司",
    "description": null,
    "evidence": "https://www.jhm-biopharma.com/zh_CN/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:26:50.539Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T17:26:50.539Z",
      "variants": [
        {
          "headline": "君合盟生物制药（杭州）股份有限公司",
          "subhead": null,
          "observed_at": "2026-11-06T17:26:50.539Z",
          "evidence": "https://www.jhm-biopharma.com/zh_CN/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "君合盟生物制药（杭州）股份有限公司",
      "subhead": null,
      "from": "2026-11-06T17:26:50.539Z",
      "to": "2026-11-06T17:26:50.539Z",
      "captures": 1,
      "evidence": "https://www.jhm-biopharma.com/zh_CN/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T17:26:50.539Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Synthorx",
      "record": "https://startuphistory.org/c/synthorx.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use synthetic biology to engineer recombinant protein therapeutics for multiple disease areas."
    },
    {
      "name": "Juvena (Juvena Therapeutics)",
      "record": "https://startuphistory.org/c/juvenatherapeutics.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both develop protein therapeutics using advanced discovery and engineering platforms for tissue repair and disease."
    },
    {
      "name": "Amolyt Pharma",
      "record": "https://startuphistory.org/c/amolytpharma.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both develop peptide or protein drugs targeting endocrine diseases."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Junhemeng Biopharmaceutical” company record, https://startuphistory.org/c/jhm-biopharma.com"
}